A1 Refereed original research article in a scientific journal

Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Authors: Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Weiss Bjerrum O, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A, Nielsen JL, Hjorth-Hansen H, Porkka K

Publication year: 2011

Journal: Blood

Number in series: 12

Volume: 118

Issue: 12

First page : 3228

Last page: 3235

Number of pages: 8

ISSN: 0006-4971

DOI: https://doi.org/10.1182/blood-2011-02-336685